OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
27
Results
Show all
Save search
Copy query
Show results for
Unknown
(27)
Publication Date
Release Date
2023
(5)
2020
(5)
2026
(2)
2025
(2)
2024
(2)
2022
(2)
2021
(2)
2018
(2)
2017
(2)
2016
(1)
2015
(1)
2014
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Outcomes of switching to dasatinib after imatinib-related low-grade adverse events in patients with chronic myeloid leukemia in chronic phase: the DASPERSE study.
Not available
S-EPMC6018625
|
biostudies-literature
Cite
Separase activity distribution can be a marker of major molecular response and proliferation of CD34
+
cells in TKI-treated chronic myeloid leukemia patients.
Not available
S-EPMC7196950
|
biostudies-literature
Cite
Treatment of agitation in terminally ill patients with intranasal midazolam versus subcutaneous midazolam: study protocol for a randomised controlled open-label monocentric trial (MinTU Study).
Not available
S-EPMC10763309
|
biostudies-literature
Cite
Gene Expression Pattern of
ESPL1
,
PTTG1
and
PTTG1IP
Can Potentially Predict Response to TKI First-Line Treatment of Patients with Newly Diagnosed CML.
Not available
S-EPMC10177117
|
biostudies-literature
Cite
Cost-effectiveness of Tyrosine Kinase Inhibitor Treatment Strategies for Chronic Myeloid Leukemia in Chronic Phase After Generic Entry of Imatinib in the United States.
Not available
S-EPMC4948567
|
biostudies-literature
Cite
Clinical, morphological and genetic characteristics of patients with concurrent presence of JAK2 V617F and BCR::ABL1.
Not available
S-EPMC12274285
|
biostudies-literature
Cite
Ponatinib for CML patients in routine clinical practice: the PONDEROSA study.
Not available
S-EPMC12804319
|
biostudies-literature
Cite
The EUTOS long-term survival (ELTS) score is superior to the Sokal score for predicting survival in chronic myeloid leukemia.
Not available
S-EPMC7387299
|
biostudies-literature
Cite
Treatment-free remission after dasatinib in patients with chronic myeloid leukaemia in chronic phase with deep molecular response: Final 5-year analysis of DASFREE.
Not available
S-EPMC10524617
|
biostudies-literature
Cite
Ponatinib in the Treatment of Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Leukemia: Recommendations of a German Expert Consensus Panel with Focus on Cardiovascular Management.
Not available
S-EPMC7384349
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets